↓ Skip to main content

Strategies to overcome the main challenges of the use of CRISPR/Cas9 as a replacement for cancer therapy

Overview of attention for article published in Molecular Cancer, March 2022
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (83rd percentile)
  • Good Attention Score compared to outputs of the same age and source (73rd percentile)

Mentioned by

news
1 news outlet
twitter
6 X users

Citations

dimensions_citation
50 Dimensions

Readers on

mendeley
202 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Strategies to overcome the main challenges of the use of CRISPR/Cas9 as a replacement for cancer therapy
Published in
Molecular Cancer, March 2022
DOI 10.1186/s12943-021-01487-4
Pubmed ID
Authors

Mohammed Fatih Rasul, Bashdar Mahmud Hussen, Abbas Salihi, Bnar Saleh Ismael, Paywast Jamal Jalal, Anna Zanichelli, Elena Jamali, Aria Baniahmad, Soudeh Ghafouri-Fard, Abbas Basiri, Mohammad Taheri

X Demographics

X Demographics

The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 202 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 202 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 25 12%
Student > Ph. D. Student 17 8%
Researcher 11 5%
Student > Master 10 5%
Other 7 3%
Other 12 6%
Unknown 120 59%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 39 19%
Medicine and Dentistry 6 3%
Agricultural and Biological Sciences 5 2%
Chemistry 5 2%
Pharmacology, Toxicology and Pharmaceutical Science 4 2%
Other 18 9%
Unknown 125 62%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 March 2024.
All research outputs
#3,257,641
of 25,582,611 outputs
Outputs from Molecular Cancer
#244
of 1,939 outputs
Outputs of similar age
#74,501
of 449,768 outputs
Outputs of similar age from Molecular Cancer
#18
of 68 outputs
Altmetric has tracked 25,582,611 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,939 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.9. This one has done well, scoring higher than 87% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 449,768 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 83% of its contemporaries.
We're also able to compare this research output to 68 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.